Role of therapeutic vaccines in the control of HIV-1

被引：9
|
作者：
Kinloch-de Loes, S
机构：
[1] UCL Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, Dept HIV Thorac Med, London NW3 2PF, England
[2] UCL Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, Dept Med, London NW3 2PF, England
[3] UCL Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, Dept Immunol & Mol Pathol, London NW3 2PF, England
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2004年 / 53卷 / 04期
关键词：
immune control; immune-based therapies; HIV; highly active antiretroviral therapy;
D O I：
10.1093/jac/dkh132
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
The recent success of highly active antiretroviral therapy (HAART) has altered the prognosis of patients living with HIV-1 infection. However, there are still many challenges to be addressed if we want to develop long-term therapeutic strategies for patients, in both the Western world and resource-poor countries. In this review, the potential role for HIV-1 therapeutic vaccines in the era of HAART will be discussed in the light of the present efforts at developing immune-based therapies to complement antiviral treatment and minimize the duration of exposure to antiviral drugs.
引用
收藏
页码：562 / 566
页数：5
相关论文
共 50 条
  • [21] Role of Vpr in HIV-1 Nuclear Import: Therapeutic Implications
    Aida, Yoko
    Matsuda, Go
    CURRENT HIV RESEARCH, 2009, 7 (02) : 136 - 143
  • [22] Therapeutic immunization for the control of HIV-1: where are we now?
    Dorrell, Lucy
    INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (07) : 436 - 442
  • [23] Mucosally-targeted HIV-1 vaccines
    Wegmann, Frank
    HUMAN VACCINES, 2011, 7 (09): : 982 - 985
  • [24] Development of prophylactic vaccines against HIV-1
    Schiffner, Torben
    Sattentau, Quentin J.
    Dorrell, Lucy
    RETROVIROLOGY, 2013, 10
  • [25] HIV-1 prophylactic vaccines: state of the art
    Lelievre, Jean-Daniel
    Levy, Yves
    JOURNAL OF VIRUS ERADICATION, 2016, 2 (01) : 5 - 11
  • [26] Current advances and challenges in HIV-1 vaccines
    Rodriguez-Chavez I.R.
    Allen M.
    Hill E.L.
    Sheets R.L.
    Pensiero M.
    Bradac J.A.
    D'Souza M.P.
    Current HIV/AIDS Reports, 2006, 3 (1) : 39 - 47
  • [27] Viral vectors as potential HIV-1 vaccines
    Schnell, MJ
    FEMS MICROBIOLOGY LETTERS, 2001, 200 (02) : 123 - 129
  • [28] MOLECULAR IMMUNE SIGNATURES OF HIV-1 VACCINES
    Buonaguro, L.
    Monac, A.
    Tornesello, M. L.
    Lewis, G. K.
    Marincola, F. M.
    Buonaguro, F. M.
    INFECTION, 2009, 37 : 86 - 86
  • [29] Development of prophylactic vaccines against HIV-1
    Torben Schiffner
    Quentin J Sattentau
    Lucy Dorrell
    Retrovirology, 10
  • [30] Development of targeted adjuvants for HIV-1 vaccines
    Jun Liu
    Mario Ostrowski
    AIDS Research and Therapy, 14
12345